These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 35944926)

  • 1. Time to consider a holistic approach to the treatment of non-alcoholic fatty liver disease in obese young people?
    Byrne CD; Targher G
    Gut; 2023 Jul; 72(7):1238-1239. PubMed ID: 35944926
    [No Abstract]   [Full Text] [Related]  

  • 2. The Future of Nonalcoholic Fatty Liver Disease Treatment.
    Mazhar K
    Med Clin North Am; 2019 Jan; 103(1):57-69. PubMed ID: 30466676
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity and nonalcoholic fatty liver disease in type 1 diabetes mellitus patients.
    Muzurović E; Rizzo M; Mikhailidis DP
    J Diabetes Complications; 2022 Dec; 36(12):108359. PubMed ID: 36446208
    [No Abstract]   [Full Text] [Related]  

  • 4. Non-alcoholic fatty liver disease is a risk factor for cardiovascular and cardiac diseases: further evidence that a holistic approach to treatment is needed.
    Byrne CD; Targher G
    Gut; 2022 Sep; 71(9):1695-1696. PubMed ID: 34509980
    [No Abstract]   [Full Text] [Related]  

  • 5. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.
    Polyzos SA; Kountouras J; Mantzoros CS
    Metabolism; 2019 Mar; 92():82-97. PubMed ID: 30502373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy.
    Sanches PL; de Piano A; Campos RM; Carnier J; de Mello MT; Elias N; Fonseca FA; Masquio DC; da Silva PL; Corgosinho FC; Tock L; Oyama LM; Tufik S; Dâmaso AR
    J Clin Lipidol; 2014; 8(3):265-72. PubMed ID: 24793347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic Fatty Liver Disease in Children: Hepatic and Extrahepatic Complications.
    Selvakumar PKC; Kabbany MN; Nobili V; Alkhouri N
    Pediatr Clin North Am; 2017 Jun; 64(3):659-675. PubMed ID: 28502444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-alcoholic fatty liver disease in obese adults: clinical aspects and current management strategies.
    Pallayova M; Taheri S
    Clin Obes; 2014 Oct; 4(5):243-53. PubMed ID: 25825857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Weighty Issue of Treating Obesity in Patients With Nonalcoholic Fatty Liver Disease.
    Adams LA
    Clin Gastroenterol Hepatol; 2022 Mar; 20(3):505-507. PubMed ID: 34175461
    [No Abstract]   [Full Text] [Related]  

  • 10. [Non-alcoholic fatty liver disease and hepatocellular carcinoma - 2016].
    Pár A; Pár G
    Orv Hetil; 2016 Jun; 157(25):987-94. PubMed ID: 27287838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action.
    Bril F; Cusi K
    Diabetes Care; 2017 Mar; 40(3):419-430. PubMed ID: 28223446
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modern approach to the clinical management of non-alcoholic fatty liver disease.
    Del Ben M; Polimeni L; Baratta F; Pastori D; Loffredo L; Angelico F
    World J Gastroenterol; 2014 Jul; 20(26):8341-50. PubMed ID: 25024593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Non-alcoholic fatty liver disease and type 2 diabetes mellitus. I. Pathogenesis].
    Pár A; Wittmann I; Pár G
    Orv Hetil; 2022 May; 163(21):815-825. PubMed ID: 35598211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Beneficial effects of lifestyle intervention in non-obese patients with non-alcoholic fatty liver disease.
    Wong VW; Wong GL; Chan RS; Shu SS; Cheung BH; Li LS; Chim AM; Chan CK; Leung JK; Chu WC; Woo J; Chan HL
    J Hepatol; 2018 Dec; 69(6):1349-1356. PubMed ID: 30142427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of non-alcoholic fatty liver disease: an interpretation of the European clinical guidelines for obesity, type 2 diabetes, and digestive disease].
    He FP
    Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):119-121. PubMed ID: 28297798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lean vs. obese phenotypes of nonalcoholic fatty liver disease: similar or different?
    Chun HS; Lee M
    Clin Mol Hepatol; 2023 Apr; 29(2):377-380. PubMed ID: 36907573
    [No Abstract]   [Full Text] [Related]  

  • 17. Benefits of exenatide on obesity and non-alcoholic fatty liver disease with elevated liver enzymes in patients with type 2 diabetes.
    Shao N; Kuang HY; Hao M; Gao XY; Lin WJ; Zou W
    Diabetes Metab Res Rev; 2014 Sep; 30(6):521-9. PubMed ID: 24823873
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combining metformin therapy with caloric restriction for the management of type 2 diabetes and nonalcoholic fatty liver disease in obese rats.
    Linden MA; Lopez KT; Fletcher JA; Morris EM; Meers GM; Siddique S; Laughlin MH; Sowers JR; Thyfault JP; Ibdah JA; Rector RS
    Appl Physiol Nutr Metab; 2015 Oct; 40(10):1038-47. PubMed ID: 26394261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The intersection of nonalcoholic fatty liver disease and obesity.
    Woo Baidal JA; Lavine JE
    Sci Transl Med; 2016 Jan; 8(323):323rv1. PubMed ID: 26819197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and treatment strategies for fatty liver when obesity coexists with alcohol consumption].
    Sun FR; Wang BY
    Zhonghua Gan Zang Bing Za Zhi; 2020 Mar; 28(3):212-216. PubMed ID: 32306654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.